Estabrook Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Buy
98,244
+51
+0.1% +$5.89K 1.72% 18
2025
Q4
$10.3M Sell
98,193
-1,507
-2% -$141K 1.52% 18
2025
Q3
$8.37M Sell
99,700
-655
-0.7% -$53.9K 1.22% 24
2025
Q2
$7.94M Buy
100,355
+3,584
+4% +$285K 1.22% 23
2025
Q1
$8.69M Sell
96,771
-898
-0.9% -$83.8K 1.4% 20
2024
Q4
$9.72M Sell
97,669
-663
-0.7% -$68.4K 1.5% 18
2024
Q3
$11.2M Sell
98,332
-392
-0.4% -$46.6K 1.67% 15
2024
Q2
$12.2M Sell
98,724
-2,140
-2% -$276K 1.88% 13
2024
Q1
$13.3M Sell
100,864
-2,259
-2% -$278K 2.06% 11
2023
Q4
$11.2M Sell
103,123
-519
-0.5% -$53.9K 1.84% 12
2023
Q3
$10.7M Sell
103,642
-1,533
-1% -$165K 1.88% 13
2023
Q2
$12.1M Sell
105,175
-766
-0.7% -$87K 2.02% 10
2023
Q1
$11.3M Sell
105,941
-1,090
-1% -$118K 1.96% 13
2022
Q4
$11.9M Sell
107,031
-2,138
-2% -$219K 2.04% 12
2022
Q3
$9.4M Sell
109,169
-345
-0.3% -$30.8K 1.75% 17
2022
Q2
$9.98M Sell
109,514
-3,032
-3% -$269K 1.71% 19
2022
Q1
$9.23M Buy
112,546
+1,847
+2% +$146K 1.36% 25
2021
Q4
$8.48M Sell
110,699
-1,256
-1% -$100K 1.2% 25
2021
Q3
$8.41M Sell
111,955
-2,156
-2% -$164K 1.32% 23
2021
Q2
$8.87M Sell
114,111
-4,376
-4% -$325K 1.35% 23
2021
Q1
$8.72M Sell
118,487
-1,551
-1% -$114K 1.34% 23
2020
Q4
$9.37M Sell
120,038
-3,238
-3% -$248K 1.55% 18
2020
Q3
$9.76M Sell
123,276
-3,663
-3% -$287K 1.79% 16
2020
Q2
$9.37M Sell
126,939
-3,924
-3% -$295K 1.78% 16
2020
Q1
$9.61M Sell
130,863
-5,086
-4% -$400K 2.02% 15
2019
Q4
$11.8M Sell
135,949
-1,802
-1% -$148K 1.77% 19
2019
Q3
$11.1M Sell
137,751
-5,649
-4% -$453K 1.85% 17
2019
Q2
$11.5M Sell
143,400
-4,581
-3% -$351K 1.88% 16
2019
Q1
$11.7M Buy
147,981
+803
+0.5% +$60.1K 1.95% 17
2018
Q4
$10.7M Sell
147,178
-3,381
-2% -$239K 1.99% 17
2018
Q3
$10.2M Sell
150,559
-3,732
-2% -$238K 1.54% 23
2018
Q2
$8.94M Sell
154,291
-5,248
-3% -$296K 1.41% 25
2018
Q1
$8.29M Sell
159,539
-2,135
-1% -$115K 1.3% 26
2017
Q4
$8.68M Buy
161,674
+5,045
+3% +$280K 1.31% 28
2017
Q3
$9.57M Sell
156,629
-5,899
-4% -$358K 1.49% 24
2017
Q2
$9.94M Sell
162,528
-4,910
-3% -$299K 1.58% 27
2017
Q1
$10.2M Sell
167,438
-4,706
-3% -$286K 1.59% 27
2016
Q4
$9.67M Sell
172,144
-27,198
-14% -$1.59M 1.52% 26
2016
Q3
$11.9M Sell
199,342
-4,982
-2% -$291K 1.74% 20
2016
Q2
$11.2M Sell
204,324
-15,742
-7% -$838K 1.68% 22
2016
Q1
$11.1M Buy
220,066
+20,169
+10% +$988K 1.64% 22
2015
Q4
$10.1M Sell
199,897
-10,165
-5% -$512K 1.46% 27
2015
Q3
$9.9M Sell
210,062
-6,159
-3% -$327K 1.43% 27
2015
Q2
$11.7M Sell
216,221
-10,777
-5% -$604K 1.45% 28
2015
Q1
$12.5M Sell
226,998
-6,218
-3% -$352K 1.45% 28
2014
Q4
$12.6M Sell
233,216
-2,542
-1% -$142K 1.39% 29
2014
Q3
$13.3M Sell
235,758
-5,181
-2% -$291K 1.43% 31
2014
Q2
$13.3M Sell
240,939
-56
-0% -$3.06K 1.37% 32
2014
Q1
$13.1M Buy
240,995
+20,565
+9% +$1.06M 1.33% 32
2013
Q4
$10.5M Buy
220,430
+167,485
+316% +$7.66M 1.08% 34
2013
Q3
$2.41M Sell
52,945
-314
-0.6% -$14.3K 0.26% 65
2013
Q2
$2.36M Buy
+53,259
New +$2.38M 0.25% 66

Other funds holding MRK

Estabrook Capital Management's MRK Position: Q1 2026 in Review

Estabrook Capital Management increased its Merck (MRK) stake by 0.05% in Q1 2026, buying an estimated $5.89K and bringing the position to 98,244 shares worth $11.8M. The position accounts for 1.72% of the portfolio, ranked #18.

Estabrook Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.3M in Q3 2014. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Estabrook Capital Management held 98,244 shares of Merck worth $11.8M as of Q1 2026.
  • Estabrook Capital Management bought 51 Merck shares in Q1 2026, an estimated $5.89K.
  • Merck made up 1.72% of Estabrook Capital Management's portfolio in Q1 2026, its #18 holding.
  • Estabrook Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Estabrook Capital Management's Merck position peaked at $13.3M in Q3 2014.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.